ID: ALA5170757

Max Phase: Preclinical

Molecular Formula: C21H28N8O7S

Molecular Weight: 536.57

Associated Items:

Representations

Canonical SMILES:  Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1CCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C21H28N8O7S/c22-17-9(4-28(21(34)27-17)13-3-10(31)11(5-30)35-13)1-2-37-6-12-15(32)16(33)20(36-12)29-8-26-14-18(23)24-7-25-19(14)29/h4,7-8,10-13,15-16,20,30-33H,1-3,5-6H2,(H2,22,27,34)(H2,23,24,25)/t10-,11+,12+,13+,15+,16+,20+/m0/s1

Standard InChI Key:  XDELFONZCZTHLD-FZQXZCJRSA-N

Associated Targets(Human)

DNA (cytosine-5)-methyltransferase 1 978 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 536.57Molecular Weight (Monoisotopic): 536.1802AlogP: -2.22#Rotatable Bonds: 8
Polar Surface Area: 229.91Molecular Species: NEUTRALHBA: 16HBD: 6
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.46CX Basic pKa: 4.92CX LogP: -2.69CX LogD: -2.69
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.17Np Likeness Score: 0.76

References

1. Lamiable-Oulaidi F, Harijan RK, Shaffer KJ, Crump DR, Sun Y, Du Q, Gulab SA, Khan AA, Luxenburger A, Woolhouse AD, Sidoli S, Tyler PC, Schramm VL..  (2022)  Synthesis and Characterization of Transition-State Analogue Inhibitors against Human DNA Methyltransferase 1.,  65  (7.0): [PMID:35324190] [10.1021/acs.jmedchem.1c01869]

Source